These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 6751175)
1. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175 [TBL] [Abstract][Full Text] [Related]
2. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. Wada M Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781 [TBL] [Abstract][Full Text] [Related]
4. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association. Br J Dis Chest; 1981 Apr; 75(2):141-53. PubMed ID: 7023526 [TBL] [Abstract][Full Text] [Related]
6. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047 [TBL] [Abstract][Full Text] [Related]
7. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946 [TBL] [Abstract][Full Text] [Related]
8. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study. Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490 [TBL] [Abstract][Full Text] [Related]
9. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
11. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
12. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study. Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933 [TBL] [Abstract][Full Text] [Related]
13. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
15. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Jindani A; Nunn AJ; Enarson DA Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185 [TBL] [Abstract][Full Text] [Related]
16. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation. S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423 [TBL] [Abstract][Full Text] [Related]
18. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study. Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015 [TBL] [Abstract][Full Text] [Related]
19. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy. Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829 [TBL] [Abstract][Full Text] [Related]
20. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]